Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Revolution Medicines Inc (RVMD)

Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Revolution Medicines to Showcase Progress Across RAS(ON) Targeted Oncology Pipeline with Multiple Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting GlobeNewswire - Tue Mar 17, 5:37PM CDT

REDWOOD CITY, Calif., March 17, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq:RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted...

RVMD : 92.51 (-0.75%)
Revolution Medicines Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress GlobeNewswire - Wed Feb 25, 3:02PM CST

On track for readout of RASolute 302, a Phase 3 trial of daraxonrasib in second line metastatic PDAC, in first half of 2026 Continues to advance broad late-stage pipeline, with five ongoing Phase 3 trials...

RVMD : 92.51 (-0.75%)
Revolution Medicines to Participate in TD Cowen 46th Annual Health Care Conference GlobeNewswire - Tue Feb 24, 3:05PM CST

REDWOOD CITY, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted...

RVMD : 92.51 (-0.75%)
Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2025 After Market Close on February 25, 2026 GlobeNewswire - Wed Feb 18, 3:05PM CST

REDWOOD CITY, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted...

RVMD : 92.51 (-0.75%)
Revolution Medicines to Participate in Guggenheim Securities Emerging Outlook: Biotech Summit 2026 GlobeNewswire - Wed Feb 4, 3:05PM CST

REDWOOD CITY, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted...

RVMD : 92.51 (-0.75%)
Revolution Medicines Doses First Patient in Clinical Trial Evaluating RMC-5127, a RAS(ON) G12V-Selective Inhibitor GlobeNewswire - Thu Jan 29, 7:00AM CST

REDWOOD CITY, Calif., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced...

RVMD : 92.51 (-0.75%)
Trader at NYSE by Orhan Akkurt via Shutterstock
Stock Index Futures Gain on Tech Boost, FOMC Meeting and Earnings in Focus Barchart - Tue Jan 27, 5:23AM CST

March S&P 500 E-Mini futures (ESH26) are up +0.26%, and March Nasdaq 100 E-Mini futures (NQH26) are up +0.60% this morning, buoyed by gains in technology stocks, while investors await the start of the...

CVS : 70.08 (-1.55%)
AAPL : 248.80 (-1.62%)
ANET : 120.77 (-1.45%)
TXN : 190.33 (-1.59%)
UNH : 259.02 (-3.37%)
CRWV : 74.81 (-7.01%)
UNP : 238.79 (-0.17%)
STX : 380.07 (+0.34%)
RTX : 189.71 (-1.63%)
NQH26 : 24,291.78s (-0.30%)
PUM.D.DX : 21.310 (-1.23%)
AMD : 201.99 (-0.87%)
NASDAQ sign at times square at night by Lucky-photographer via iStock
Stocks Close Higher Ahead of Heavy Earnings Week and FOMC Meeting Barchart - Mon Jan 26, 3:32PM CST

The S&P 500 Index ($SPX ) (SPY ) on Monday rose +0.63%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +0.68%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.59%. March E-mini S&P futures (ESH26...

AAPL : 248.80 (-1.62%)
CSCO : 79.92 (-2.73%)
HL : 17.93 (+4.30%)
CDE : 17.13 (+5.94%)
$IUXX : 23,132.77 (-1.93%)
ZNM26 : 110-050s (-0.01%)
CRWV : 74.81 (-7.01%)
CRML : 7.04 (-5.25%)
TSLA : 361.83 (-2.76%)
ESM26 : 6,412.25s (-1.73%)
CTSH : 59.73 (-1.70%)
$DOWI : 45,166.64 (-1.73%)
Inside NYSE by Orhan Akkurt via Shutterstock
Stocks See Support Ahead of Heavy Earnings Week and FOMC Meeting Barchart - Mon Jan 26, 10:41AM CST

The S&P 500 Index ($SPX ) (SPY ) today is up +0.51%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.26%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.57%. March E-mini S&P futures (ESH26...

GOOGL : 274.34 (-2.34%)
AAPL : 248.80 (-1.62%)
CSCO : 79.92 (-2.73%)
HL : 17.93 (+4.30%)
CDE : 17.13 (+5.94%)
$IUXX : 23,132.77 (-1.93%)
ZNM26 : 110-050s (-0.01%)
MSFT : 356.77 (-2.51%)
CRWV : 74.81 (-7.01%)
CRML : 7.04 (-5.25%)
TSLA : 361.83 (-2.76%)
ESM26 : 6,412.25s (-1.73%)
Road sign of New York Wall street corner Broad street by Mezzotint via Shutterstock
Stocks See Support Ahead of Heavy Earnings Week and FOMC Meeting Barchart - Mon Jan 26, 8:59AM CST

The S&P 500 Index ($SPX ) (SPY ) today is up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.33%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.07%. March E-mini S&P futures (ESH26...

META : 525.72 (-3.99%)
AAPL : 248.80 (-1.62%)
MP : 51.80 (+0.19%)
CSCO : 79.92 (-2.73%)
HL : 17.93 (+4.30%)
CDE : 17.13 (+5.94%)
$SPX : 6,368.85 (-1.67%)
USAR : 15.42 (-3.62%)
$IUXX : 23,132.77 (-1.93%)
NQM26 : 23,328.50s (-1.96%)
QQQ : 562.58 (-1.95%)
ZNM26 : 110-050s (-0.01%)

Barchart Exclusives

Only 1 of These Top 2 REITs Is Built to Pay You for Generations Barchart - Fri Mar 27, 6:00PM CDT
VICI or Realty Income? One offers higher yield and growth, while the other may benefit more when rate cuts arrive. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.